1. Home
  2. STTK vs LAND Comparison

STTK vs LAND Comparison

Compare STTK & LAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.95

Market Cap

459.4M

Sector

Health Care

ML Signal

HOLD

Logo Gladstone Land Corporation

LAND

Gladstone Land Corporation

HOLD

Current Price

$10.37

Market Cap

431.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
LAND
Founded
2016
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
459.4M
431.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
LAND
Price
$6.95
$10.37
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$7.60
N/A
AVG Volume (30 Days)
502.9K
452.4K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
5.43%
EPS Growth
53.02
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$8.47
52 Week High
$7.68
$13.00

Technical Indicators

Market Signals
Indicator
STTK
LAND
Relative Strength Index (RSI) 65.29 42.30
Support Level $5.75 $9.97
Resistance Level N/A $10.80
Average True Range (ATR) 0.47 0.27
MACD 0.03 -0.00
Stochastic Oscillator 61.66 53.76

Price Performance

Historical Comparison
STTK
LAND

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About LAND Gladstone Land Corporation

Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment: Real Estate Rental Operations. It is focused on the ownership of farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce or annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also owns farms that grow certain commodity crops (e.g., corn and beans).

Share on Social Networks: